Real-world dose escalation of biologics for moderate-to-severe psoriasis in the United States

• Main Authors: Jashin J. Wu (Author), Manish Patel (Author), Feng Zeng (Author), Ahong Huang (Author), Xing Pan (Author), Yiwen Cao (Author), Naijun Chen (Author), Huzefa Photowala (Author), Vishvas Garg (Author), Jeff Crowley (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aim To compare real-world dose escalation of risankizumab with other US Food and Drug Administration (FDA)-approved biologic treatments for management of moderate-to-severe psoriasis (PsO) in the United States. Methods The Merative® MarketScan® Research Database was used to identify adults with ≥2 m...